The first early-stage, noninvasive combination drug-device diagnostic test for Alzheimer\'s disease; detects beta amyloid aggregates in the lens of th...
There’s no risk. Start your trial today to see profiles of Cognoptix (fka Neuroptix) plus 5234 other startups.
Start Free 7 Day Trial Now